🇺🇸 Riabni in United States

485 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Product Storage Error — 165 reports (34.02%)
  2. Circumstance Or Information Capable Of Leading To Medication Error — 116 reports (23.92%)
  3. Off Label Use — 61 reports (12.58%)
  4. Intercepted Product Administration Error — 51 reports (10.52%)
  5. Fatigue — 18 reports (3.71%)
  6. Accidental Exposure To Product — 17 reports (3.51%)
  7. Intercepted Product Preparation Error — 16 reports (3.3%)
  8. Dyspnoea — 14 reports (2.89%)
  9. Infusion Related Reaction — 14 reports (2.89%)
  10. Drug Ineffective — 13 reports (2.68%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Riabni approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Riabni in United States?

Merck Sharp & Dohme LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.